Helminthic therapy and respiratory disease

⚭Home>Effects of helminthic therapy>Helminthic therapy and respiratory disease

Scientific papers

• 1995 Nov 15 Neutrophil inhibitory factor prevents neutrophil-dependent lung injury

See also

• 2025 Nov 12 Advances in interleukin-10-based therapies for pulmonary diseases: focus on targeted lung delivery systems
• 2025 Oct Interleukin-10 family cytokines: key regulators and novel therapeutic targets for respiratory diseases
• 2012 Oct 22 TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation

Acute respiratory distress syndrome (ARDS)

Acute respiratory distress syndrome (ARDS) is a type of respiratory failure characterized by rapid onset of widespread inflammation in the lungs. Symptoms include shortness of breath (dyspnea), rapid breathing (tachypnea), and bluish skin coloration (cyanosis). For those who survive, a decreased quality of life is common.

Causes may include sepsis, pancreatitis, trauma, pneumonia, and aspiration.

Acute lung injury (ALI)

Acute lung injury is a disorder of acute inflammation that causes disruption of the lung endothelial and epithelial barriers.

Asthma

See Helminthic therapy and asthma

Bronchiolitis

See Helminthic therapy and infectious diseases: Helminths and respiratory syncytial virus (RSV)

Chronic obstructive pulmonary disease (COPD)

See Helminthic therapy and chronic obstructive pulmonary disease (COPD).

COVID-19

See Helminthic therapy and COVID-19

Idiopathic pulmonary fibrosis

maybe not relevant :

• 2025 Sep 8 Selective packaging of anti-fibrotic and tumour suppressor miRNAs in extracellular vesicles of a parasitic whipworm (Conference)
• 2024 Sep 11 IL-10 deficiency aggravates cell senescence and accelerates BLM-induced pulmonary fibrosis in aged mice via PTEN/AKT/ERK pathway
• 2022 Jul 30 Overlapping of Pulmonary Fibrosis of Postacute COVID-19 Syndrome and Tuberculosis in the Helminth Coinfection Setting in Sub-Saharan Africa

Influenza

See Helminthic therapy and infectious diseases: Helminths and influenza

Interstitial lung disease (ILD)

I am using NA for interstitial lung disease that seems to have developed from RA. I inoculated in August 2016 with only 5 NA and within 10 weeks symptoms were better. [1]

Lung transplantation

See Helminthic therapy and organ transplantation

See also Helminthic therapy and cardiometabolic conditions: Ischemia-reperfusion injury (IRI)

Lung ischemia-reperfusion injury (IRI)

See Helminthic therapy and cardiometabolic conditions: Ischemia-reperfusion injury (IRI)

Nasal polyposis

See Helminthic therapy and rhinosinusitis

Pleurisy

Pleurisy, also known as pleuritis, is inflammation of the membranes that surround the lungs and line the chest cavity (pleurae).

• 2018 Feb 9 Schistosoma mansoni SmKI-1 serine protease inhibitor binds to elastase and impairs neutrophil function and inflammation

Using the carrageenan-induced pleural inflammation model, we demonstrated the ability of SmKI-1 to inhibit early events that trigger neutrophil recruitment in the pleural cavities of mice in response to inflammatory stimuli.

Pneumocystosis

• 2021 Dec 31 Prevalence of Pneumocystosis in Sub-Saharan Africa and Helminth Immune Modulation

See also Helminthic therapy and infectious diseases: Helminths and fungi

Pneumonia

Pneumonia] is an inflammatory condition of the lung primarily affecting the small air sacs known as alveoli. Pneumonia is usually caused by infection with viruses or bacteria, and less commonly by other microorganisms.

See Helminthic therapy and infectious diseases: Helminths and Streptococcus pneumoniae

Rhinosinusitis

See Helminthic therapy and rhinosinusitis

Whooping cough

Whooping cough, also known as pertussis or the 100-day cough, is a highly contagious, vaccine-preventable bacterial disease.

See Helminthic therapy and infectious diseases: Helminths and Bordetella Pertussis

Pulmonary viral infections

See

• Helminthic therapy and COVID-19
• Helminthic therapy and infectious diseases: Helminths and influenza
• Helminthic therapy and infectious diseases: Helminths and respiratory syncytial virus (RSV)

Turberculosis

See Helminthic therapy and infectious diseases: Helminths and tuberculosis (TB)

The reintroduction to the digestive tract of a controlled number of specially domesticated, mutualistic helminths (intestinal worms) in the form of microscopic eggs or larvae to reconstitute a depleted biome to treat or prevent chronic inflammation, autoimmune disease and other immune-related disorders, including allergy.

the human hookworm, Necator americanus

A microscopic organism, especially a bacterium, virus or fungus.